Biopharmaceutical company in clinical stage: Palisade Bio, Inc. (PALI)

Palisade Bio, Inc. (NASDAQ: PALI) was founded in 2005 by Seneca Biopharma, Inc. (former NASDAQ: SNCA) merged with Leading BioSciences, Inc. at the end of April 2021. Headquartered in Carlsbad, California, it is a clinical Biopharmaceutical Company , focusing on the discovery, development and commercialization of oral therapies for serious diseases related to the destruction of the mucosal barrier that protects the gastrointestinal tract.

The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/pali.html

Palisade Bio, Inc. (PALI)

Palisade Bio is a late stage biopharmaceutical company dedicated to promoting oral therapy to help patients with acute and chronic gastrointestinal complications caused by digestive enzyme damage after surgery. Palisade Bio's initial focus is to prevent gastrointestinal function damage after major surgery (referred to as "intestinal obstruction"), so as to speed up rehabilitation and reduce the length of hospital stay of patients. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/pali.html

In addition, Palisade Bio believes that its research therapy may prevent the formation of postoperative adhesions, which is a common reason for people to be readmitted for additional surgery. Palisade Bio believes that protecting intestinal integrity is the cornerstone of maintaining human health. The company's focus is to help millions of patients who undergo surgery every year to overcome numerous health conditions and complications related to acute and chronic gastrointestinal damage. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/pali.html

Decades of studies have shown that surgical injury to the intestinal tract will lead to additional digestive enzyme tissue damage and inflammation, which will lead to various acute and chronic diseases. Palisade Bio is developing a series of oral product candidates to treat diseases driven by protease (intestinal digestive enzyme) escaping from the intestine, including surgical complications and inflammation. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/pali.html

More than 30 years of pioneering scientific research has emphasized the importance of intestinal integrity for human health, as well as the possible medical complications when the intestinal epithelial barrier is destroyed. Palisade Bio is applying its own internal efforts for 15 years to develop new therapies aimed at improving human health by protecting the intestinal tract. The protection of intestinal integrity is the cornerstone of human health and plays a key role in both acute intensive care medical conditions and severe chronic diseases. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/pali.html

The intestinal epithelium is a layer of cells that forms the protective inner layer of the intestine. It helps to promote nutrition absorption, while protecting the abdomen from the adverse environment of the intestinal tract. The substances in the intestinal tract include corrosive digestive enzymes, invasive pathogens and potentially harmful dietary antigens. If damaged, the intestinal epithelium can allow effective digestive enzymes to damage the gastrointestinal tract and surrounding organs and cause extensive complications. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/pali.html

Product line

Palisade Bio, Inc. (PALI)